Interestingly, increased expression of the SOST gene encoding sclerostin and elevated levels of this protein are found in cell lines and cells isolated from patients with primary and metastatic bone cancers, including osteosarcoma, chondrosarcoma, multiple myeloma, as well as breast and prostate cancer15–17. Here, SOST is linked to prostatitis.